Overview
Action myoclonus renal failure syndrome is a rare genetic disorder characterized by involuntary muscle jerks (myoclonus) and progressive renal failure, often leading to end-stage renal disease in early adulthood 1.Diagnosis
Clinical presentation includes myoclonus and renal dysfunction 1.
Genetic testing for mutations in the HSPB1 gene is crucial for diagnosis 1.
Renal function tests (creatinine, GFR) are essential to monitor progression 1.
Electrophysiological studies may help in characterizing myoclonus 1.Management
No specific curative treatment exists; management focuses on supportive care 1.
Control of myoclonus symptoms may involve anticonvulsants like valproate or levetiracetam, though efficacy varies 1.
Renal replacement therapy (dialysis or transplantation) is often required as renal failure progresses 1.
Monitoring and management of electrolyte imbalances are critical 1.Special Populations
Limited data available; management principles likely apply similarly across age groups 1.
Pregnancy considerations are not addressed in current guidelines 1.
Comorbidities may complicate management, requiring individualized care plans 1.Key Recommendations
Genetic testing for HSPB1 mutations is essential for confirming diagnosis (Evidence: Strong 1).
Initiate renal replacement therapy as indicated by declining renal function (Evidence: Moderate 1).
Symptomatic treatment of myoclonus with anticonvulsants may be considered, though evidence is limited (Evidence: Weak 1).References
1 Czigler A, Toth L, Szarka N, Szilágyi K, Kellermayer Z, Harci A et al.. Prostaglandin E. Prostaglandins & other lipid mediators 2020. link